Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning

Journal of Bone and Joint Surgery - Series B

Volumn 82, Issue 5, 2000, Pages 760-767

  Watanabe, H ^a   Shinozaki, T ^a   Yanagawa, T ^a   Aoki, J ^a   Tokunaga, M ^a   Inoue, T ^a   Endo, K ^a   Mohara, S ^a   Sano, K ^a   Takagishi, K ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; BONE TUMOR; CALCULATION; CANCER SURGERY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE TUMOR; NEURILEMOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY;

EID: 0033879974     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.82B5.9824     Document Type: Article

References (41)

1. Musculoskeletal neoplasms: Static and dynamic Gd-DTPA-enhanced MR imaging
2. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: Basic principles and clinical applications
3. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture
4. PET FDG studies in oncology
5. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection
6. Changes in glucose uptake by malignant gliomas: Preliminary study of prognostic significance
7. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma
8. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma
9. Noninvasive grading of musculoskeletal tumors using PET
10. Metabolic imaging of human extremity musculoskeletal tumors by PET
11. Fluorine-18-fluorodeoxy-glucose PET imaging of soft-tissue sarcoma
12. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas
13. Demonstration of recurrent dedifferentiated liposarcoma of the spermatic cord by FDG-PET
14. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas
15. PET evaluation of soft-tissue masses with fluorine-18-fluoro-2-deoxy-D-glucose
16. 18F]2-deoxy-2-fluoro-D-glucose
17. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide
18. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor
19. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells
20. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells
21. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence
22. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma
23. 18F-alpha-methyltyrosine using a separation and purification system
24. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumor
25. Isolation of mRNA from mammalian cells
26. Benign versus malignant intraosseous lesions: Discrimination by means of PET with 2-[F-18] fluore-2-deoxy-D-glucose
27. In vivo utilization of substrate by human sarcoma-bearing limbs
28. Quantitative [F-18] fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma
29. MRI of soft tissue tumors
30. Synovial sarcoma
31. FDG-PET in infectious lesions: The detection and assessment of lesion activity
32. F-18 alpha-methyl tyrosine PET studies in patients with brain tumors
33. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis
34. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: Preliminary results
35. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma
36. Metastasis
37. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models
38. Targeting glucose transporters for tumor imaging 'sweet' idea, 'sour' result
39. Autocrine motility factor in pulmonary adenocarcinomas: Results of an immunohistochemical study